Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesOmigapil ameliorates the pathology of muscle dystrophy caused by laminin-2 deficiency
Journal of Pharmacology and Experimental Therapeutics, 09/21/09
Erb M et al. – The data qualify omigapil, which is in late phase of clinical development for human use, as a drug candidate for the treatment of MDC1A.
Related Articles
MR imaging in Duchenne muscular dystrophy: Quantification of T1-weighted signal, contrast uptake, and the effects of exercise
Journal of Magnetic Resonance Imaging, 11/09/09
Relevance Score: 65%
Exon Skipping Drug Prevents Muscle Wasting and Maintains Muscle Function in Severely Affected, Dystrophin Deficient Mice
AVI BioPharma, 10/21/09
Relevance Score: 65%
Regional Changes in Bone Area and Bone Mineral Content in Boys with Duchenne Muscular Dystrophy Receiving Corticosteroid Therapy
The Journal of Pediatrics, 11/23/09
Relevance Score: 64%
Abdominal volume contribution to tidal volume as an early indicator of respiratory impairment in Duchenne Muscular Dystrophy
European Respiratory Journal, 10/29/09
Relevance Score: 64%
Fukutin gene retrotransposal insertion in a non-Japanese Fukuyama congenital muscular dystrophy (FCMD) patient
American Journal of Medical Genetics, 10/21/09
Relevance Score: 64%
Today in Basic Science...keeping you current
Receive free subspecialty "5-minute updates" via email
No evidence for functional selectivity of proxyfan at the human histamine H3-receptor coupled to defined Gi/Go protein heterotrimers
Journal of Pharmacology and Experimental Therapeutics, 12/04/09
Metabolic Fate of Lactoferricin Based Antimicrobial Peptides: Effect of Truncation and Incorporation of Amino Acid Analogs on the in vitro Metabolic Stability
Journal of Pharmacology and Experimental Therapeutics, 12/04/09
Targeting of a mutant plasminogen activator to circulating red blood cells for prophylactic fibrinolysis
Journal of Pharmacology and Experimental Therapeutics, 12/04/09
Sponsor
Article Search
Sponsor